课题基金 / 基金详情

项目摘要

项目成果

Suresh B Boppana的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):先天性CMV感染是儿童听力损失和脑部疾病的主要原因,医学研究所已将CMV作为疫苗开发的目标。先前的研究表明,妊娠期间的原发性母体感染是损害性先天性感染的最重要危险因素。然而,最近的研究,包括我们之前在Ballabgarh进行的MCHDR研究,表明先天性CMV感染在接近普遍CMV血清免疫的母体人群中发生率较高(1%至2%)。这些研究还表明,CMV相关的感音神经性听力损失(SNHL)发生在CMV血清阳性率高的人群中,发生率与美国和北方观察到的相似,因此,先天性CMV感染对发展中国家人群的公共卫生影响可能是显著的。我们建议测试的假设,先天性CMV感染有助于在印度的SNHL的一个显着的比例。这一假设将在两个具体目标中得到解决:(1)通过筛查新生儿的CMV和听力损失,确定印度Ballabgarh综合农村卫生服务项目(CRHSP)出生的婴儿中CMV相关SNHL的贡献,以及(2)评估适用于资源贫乏环境中新生儿CMV筛查的更新、快速、简单和基于PCR的方法的实用性。CRHSP拥有出色的基础设施,Ballabgarh为CRHSP服务的研究人群提供了方便,UAB和AIIMS研究者之间的持续合作关系为拟议研究提供了显着优势。此外,我们希望在农村人口出生时对SNHL进行初步估计,并在社区层面上测试新生儿听力筛查计划的可行性。拟议的研究将提供有关出生时听力损失的总体患病率和CMV相关SNHL在人群中的贡献的重要信息,早期识别SNHL风险增加的儿童,以及制定SNHL儿童的干预策略。拟议的研究计划还包括并强调培训和技术转让部分。 公共卫生相关性:我们建议检验这一假设,即在印度出生或新生儿期SNHL的显着比例是继发于先天性CMV感染。这项拟议的研究还将探讨在农村社区的初级卫生中心对新生儿进行听力功能筛查的可行性。预计本研究的结果将提供印度新德里附近低收入半城市人群出生时SNHL患病率的可靠估计。此外,我们将评估简单可靠的方法,可用于资源匮乏的设置,以筛选先天性CMV感染的婴儿。
英文摘要
DESCRIPTION (provided by applicant): Congenital CMV infection is a leading cause of hearing loss and brain disease in children and the Institute of Medicine has targeted CMV for vaccine development. Previous studies have suggested that primary maternal infection during pregnancy was the most significant risk factor for damaging congenital infections. However, more recent studies including our previous MCHDR study at Ballabgarh have shown congenital CMV infection occurs at higher rate (1% to 2%) in maternal populations with near universal CMV seroimmunity. These studies have also suggested that CMV-related sensorineural hearing loss (SNHL) occurs in populations with high CMV seroprevalence at a rate similar to that observed in the U.S. and Northern Europe thus, the public health impact of congenital CMV infection in populations of developing countries could be significant. We propose to test the hypothesis that congenital CMV infection contributes to a significant proportion of SNHL in India. This hypothesis will be addressed in two specific aims: (1) To determine the contribution of CMV- related SNHL in infants born at the Comprehensive Rural Health Services Project (CRHSP) in Ballabgarh, India by screening newborns for CMV and hearing loss, and (2) To evaluate the utility of newer, rapid, simple and simple PCR-based methods suitable for newborn CMV screening in resource-poor settings. The presence of an excellent infrastructure at CRHSP, Ballabgarh providing ready access to the study population served by the CRHSP and the ongoing collaborative relationship between the investigators at UAB and at AIIMS provides significant advantage to the proposed studies. In addition, we expect to develop preliminary estimates of SNHL at birth in the rural population and to test the feasibility of newborn hearing screening program at the community level. The proposed studies will provide crucial information about the overall prevalence of hearing loss at birth and the contribution of CMV-related SNHL in the population, an early identification of children at increased risk for SNHL, and the development of intervention strategies for children with SNHL. The proposed research plan also incorporates and emphasizes the training and technology transfer components. PUBLIC HEALTH RELEVANCE: We propose to test the hypothesis that a significant proportion of SNHL at birth or neonatal period in India is secondary to congenital CMV infection. The proposed study will also examine the feasibility of screening newborns for hearing function at the primary health center setting in a rural community. It is expected that the results of this study to provide a reliable estimate of SNHL prevalence at birth in a low-income semi-urban population near New Delhi, India. In addition, we will evaluate simple and reliable methods that can be used in resource-poor settings to screen infants for congenital CMV infection.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Adaptive Immunity and Persistent SARS-CoV-2 Replication
Adaptive Immunity and Persistent SARS-CoV-2 Replication
Adaptive Immunity and Persistent SARS-CoV-2 Replication
Adaptive Immunity and Persistent SARS-CoV-2 Replication
海外基金